Toshiba America Medical Systems has received U.S. Food and Drug Administration (FDA) clearance for its VeloCT console.
The console upgrade offers enhancements for patient safety, dose management, and workflow for existing Aquilion 32, Aquilion 64, and Aquilion CX CT systems manufactured between 2006 and 2012, according to the vendor.
It includes Toshiba's adaptive iterative dose reduction (AIDR) 3D software, which provides system enhancements to reduce radiation dose, Toshiba said. VeloCT also includes National Electrical Manufacturers Association (NEMA) XR 25 dose-check software, as well as support for radiation dose tracking and the Integrating the Healthcare Enterprise (IHE) Structured Dose Report.
Toshiba said it has also incorporated advanced hardware to facilitate accelerated workflow.
